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 2012 EMBO Molecular MedicineThe skin provides an efficient permeability barrier and protects from microbial
invasion and oxidative stress. Here, we show that these essential functions are
linked through the Nrf2 transcription factor. To test the hypothesis that acti-
vation of Nrf2 provides skin protection under stress conditions, we determined
the consequences of pharmacological or genetic activation of Nrf2 in keratino-
cytes. Surprisingly, mice with enhanced Nrf2 activity in keratinocytes developed
epidermal thickening, hyperkeratosis and inflammation resembling lamellar
ichthyosis. This resulted from upregulation of the cornified envelope proteins
small proline-rich proteins (Sprr) 2d and 2h and of secretory leukocyte peptidase
inhibitor (Slpi), which we identified as novel Nrf2 targets in keratinocytes. Since
Sprrs are potent scavengers of reactive oxygen species and since Slpi has
antimicrobial activities, their upregulation contributes to Nrf2’s protective func-
tion. However, it also caused corneocyte fragility and impaired desquamation,
followed by alterations in the epidermal lipid barrier, inflammation and over-
expression of mitogens that induced keratinocyte hyperproliferation. These
results identify an unexpected role of Nrf2 in epidermal barrier function, which
needs to be considered for pharmacological use of Nrf2 activators.INTRODUCTION
Reactive oxygen species (ROS) are highly aggressive molecules
that are produced in various cellular reactions, for example in
the respiratory chain. ROS levels are strongly elevated inETH Zurich, Zurich,
, c/o Kekule´-Institute
sity of Bonn, Bonn,
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icine, German Sport
41 44 633 1174;
þ41 44 633 1174;response to different insults, such as exposure to xenobiotics or
UV irradiation. While low levels of ROS are required for efficient
intracellular signalling, high levels are deleterious, as they
damage cellular macromolecules including DNA. ROS-induced
cell damage is involved in the pathogenesis of major human
diseases including cancer and neurodegenerative diseases (de
Vries et al, 2008; Liou & Storz, 2010; Perez-Matute et al, 2009).
To cope with ROS, cells have evolved antioxidant defense
mechanisms. A central player is nuclear factor erythroid derived
2, like 2 (Nrf2), which regulates the expression of numerous
detoxifying enzymes and antioxidant proteins and is highly
conserved throughout evolution (Sykiotis & Bohmann, 2010).
Nrf2 knockout (ko) mice show a reduction in the basal and
inducible expression of cytoprotective genes, and are more
susceptible to the toxicity of ROS-inducing agents and electro-
philes (Copple et al, 2008).
Vice versa, Nrf2 activation efficiently protected cells from ROS
damage in vitro and in vivo. Most importantly, a variety of Nrf2-
activating substances showed a potent chemopreventive and
anti-inflammatory function in animal models of cancer (KunduEMBO Mol Med 4, 364–379 www.embomolmed.org
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Xu et al, 2006). Clinical trials confirmed a chemopreventive
function of the Nrf2 activators sulforaphane and triterpenoids in
humans (Liby et al, 2007; Yanaka et al, 2009). Promising results
with Nrf2 activators have also been obtained in animal models
of neurodegenerative diseases (de Vries et al, 2008). Further-
more, diet restriction-induced longevity in Caenorhabditis
elegans (C. elegans) requires the Nrf2 homologue Skn-1 (Bishop
& Guarente, 2007).
In spite of these positive and encouraging results, Nrf2
activation may also have adverse effects. Constitutive activation
of Nrf2 through genetic or epigenetic mechanisms or upregula-
tion of Nrf2 expression by oncogenes have been identified in
various tumours, which are associated with enhanced cell
proliferation, reduced apoptosis and enhanced chemoresistance
of tumour cells (Denicola et al, 2011; Hayes & McMahon, 2009).
It is therefore essential to examine the consequences of
pharmacological use of Nrf2 activators and their effect on
tissue homeostasis before they are brought into the clinic.
The skin, which serves as a protective barrier against the
environment, is frequently challenged by harmful insults that
cause oxidative stress. Pharmacological activation of Nrf2 in the
skin protected against chemically- and UV-induced carcinogen-
esis (Dinkova-Kostova et al, 2006; Xu et al, 2006). Furthermore,
transgenic mice expressing a constitutively active Nrf2 mutant
in keratinocytes were remarkably resistant to UVB-induced ROS
damage (Scha¨fer et al, 2010). As a result of these studies several
patents for the use of Nrf2 activators as skin protecting agents
were filed, for example for sulforaphane [publication number
KR20080045083 (A)] or oltipraz [publication number
KR20020075954 (A)]. It needs to be considered, however, that
mice lacking the Nrf2 antagonist Keap1 show hyperkeratosis in
the skin (Taguchi et al, 2010; Wakabayashi et al, 2003) and that
Nrf2-activating mutations have been identified in cutaneous
squamous cell carcinomas (Kim et al, 2010). Thus, activation of
Nrf2 in the skin may have harmful effects.
Here, we show that Nrf2 links antioxidant defense mechan-
isms in the epidermis with control of the permeability barrier
and antimicrobial defense. While limited activation of these
mechanisms is beneficial, prolonged activation of Nrf2 in the
epidermis caused corneocyte fragility and impaired desquama-
tion, resulting in the development of an ichthyosis-like skin
disease. These findings unravelled an unexpected role of Nrf2 in
skin homeostasis and disease that goes well beyond its well-
characterized antioxidant function.RESULTS
Genetic activation of Nrf2-mediated gene expression in
keratinocytes disrupts skin homeostasis
To specifically activate Nrf2 in keratinocytes in vivo and to
exclude potential Nrf2-independent effects of pharmacological
Nrf2 activators, we generated transgenic mice expressing a
constitutively active Nrf2 mutant (caNrf2) in keratinocytes. We
previously reported on the characterization of this mutant and
generation of mice expressing caNrf2 under control of a b-actinwww.embomolmed.org EMBO Mol Med 4, 364–379promoter (Scha¨fer et al, 2010) using a construct containing the
caNrf2 cDNA preceded by a floxed stop cassette. Crossing of b-
actin-caNrf2 mice with transgenic mice expressing Cre recom-
binase under control of the keratin 5 (K5) promoter allowed Cre-
induced activation of Nrf2-mediated gene expression in
keratinocytes (Scha¨fer et al, 2010).
To further characterize the phenotype of these mice and to
identify a possible dose-dependency, we generated mice
expressing the same transgene but with a CMV enhancer
upstream of the b-actin promoter (Sawicki et al, 1998; Fig 1A).
These mice were crossed with K5-cre mice and the progeny was
named K5cre-CMVcaNrf2 mice (Fig 1A). RNase protection assay
(RPA) using RNAs from skin of mice hemizygous for the caNrf2
transgene revealed an approximately fourfold higher expression
of caNrf2 in K5cre-CMVcaNrf2 compared to K5cre-caNrf2 mice
(Fig 1B). Consequently, a higher expression of the Nrf2 target
genes NAD(P)H dehydrogenase, chinone 1 (Nqo1), glutamate
cysteine ligase catalytic subunit (Gclc) and modifier subunit
(Gclm) and sulphiredoxin (Srxn) was observed (Fig 1C).
K5cre-CMVcaNrf2 mice displayed reduced body size and
weight as well as hair loss (Fig S1A of Supporting information
and Fig 1D). Their skin appeared dry and there was considerable
scaling. Histological analysis revealed a thickened viable
epidermis (acanthosis) and stratum corneum (SC) (hyperker-
atosis), enlarged sebaceous glands and hair follicle abnormal-
ities (Fig 1E). Hyperkeratosis was also described in Keap1-
deficient mice, which die, however, 3 weeks after birth from
malnutrition due to hyperkeratosis in the esophagus (Waka-
bayashi et al, 2003). By contrast, K5cre-CMVcaNrf2 mice are
viable and do not show hyperkeratosis in the esophagus, oral
epithelium, tongue and forestomach.
Pharmacological Nrf2 activators cause phenotypic
abnormalities resembling caNrf2 transgenic mice
To determine if activation of endogenous Nrf2 causes similar
abnormalities, newborn wild-type (WT) mice (FVB/N/C57BL/6
mixed background) were topically treated with the Nrf2
activators sulforaphane or tert-butyl hydrochinone (tBHQ) or
with vehicle. Indeed, treatment with the Nrf2 activators also
caused hyperkeratosis, acanthosis and sebaceous gland enlar-
gement (Fig 2A). A strong increase in the expression of Nqo1,
Gclc, Gclm and glutathione S-transferase alpha 3 (Gsta3)
revealed efficient Nrf2 activation under these conditions
(Fig 2B).
Morphometrical analysis confirmed a significant increase in
the thickness of the viable epidermis in sulforaphane- and tBHQ-
treated mice (Fig 2C), but only a mild increase in vehicle-treated
animals. The stronger effect of tBHQ compared to sulforaphane
correlates with the extent of Nrf2 target gene activation (Fig 2B).
Most importantly, the tBHQ-induced increase in epidermal
thickness was not observed in Nrf2 ko mice (C57BL/6
background), whereas it was reproduced in their wt littermates
(Fig 2D). These findings strongly suggest that the epidermal
abnormalities observed in caNrf2 transgenic mice indeed result
from activation of Nrf2-mediated gene expression. Therefore,
caNrf2 transgenic mice represent a valuable model to study the
consequences of Nrf2 activation in the skin. 2012 EMBO Molecular Medicine 365
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Figure 1. Generation and initial characterization
of K5cre-CMVcaNrf2 mice.
A. Scheme of the transgene construct, including
CMV enhancer/b-actin promoter, floxed STOP
cassette, caNrf2 cDNA, internal ribosomal entry
site (IRES), enhanced green fluorescent protein
(EGFP) cDNA and polyA tract. These mice were
crossed with Keratin5-Cre mice.
B. RPA for caNrf2/Nrf2 and glyceraldehyde 3-
phosphate dehydrogenase (Gapdh) using epi-
dermal RNA of control (K5cre, tg/wt), K5cre-
caNrf2 and K5cre-CMVcaNrf2 (tg/tg) mice and
tRNA (negative control). Probe: 104 counts per
minute of the hybridization probe.
C. qRT-PCR analysis of Nqo1, Gclc, Gclm and Srxn
relative to Gapdh using RNAs from back skin of
adult K5cre-caNrf2 (N¼ 3), K5cre-CMVcaNrf2
(N¼ 3) and control mice (N¼3/2). Expression in
control mice was arbitrarily set as 1.
D. Control and K5cre-CMVcaNrf2 mice at P19 (left).
Tg/tg mice with different severity of the pheno-
type at P12 (right).
E. Longitudinal sections of the back skin of tg/wt
(top) and tg/tg (bottom) K5cre-CMVcaNrf2 mice
at P19. Scale bar, 100mm. E, epidermis; HF, hair
follicle; SC, stratum corneum; SG, sebaceous
gland.
366Activation of Nrf2 causes an ichthyosis-like phenotype
The epidermal abnormalities observed in mice after Nrf2
activation are remarkably reminiscent to those seen in
the heterogeneous group of ichthyosis diseases, in particular
in lamellar ichthyosis (Hohl & Williams, 2011). Therefore,
we determined if there are similarities in the underlying
pathomechanisms. We focused on the epidermal phenotype
in K5cre-CMVcaNrf2 mice, whereas, sebaceous gland and
hair follicle abnormalities will be characterized in a separate
study.
The epidermal phenotype of K5cre-CMVcaNrf2 mice devel-
oped in the first postnatal weeks and was most severe in mice at
the age of 1–3 months. However, the phenotype frequently
ameliorated upon aging as shown formice at the age of 6months
(Fig 3A). This time course correlates with a higher expression of
the caNrf2 transgene in adult compared to newborn mice and
with a decline of expression in aged mice (Supporting
information Fig S1B). 2012 EMBO Molecular MedicineImmunostaining of skin sections with antibodies against
epidermal differentiation markers was performed at P32, when
hairs of K5cre-CMVcaNrf2 and control mice were both in
anagen. Loricrin (Lor), involucrin (Inv), K10 and K14 showed an
extended expression in the interfollicular epidermis of K5cre-
CMVcaNrf2 mice, but were still normally distributed (Fig 3B).
Interfollicular expression of K6was not observed (Fig 3B). Thus,
caNrf2 expression does not generally interfere with the normal
epidermal differentiation program.
Similar to the situation seen in ichthyosis (Elias et al, 2008),
basal keratinocytes were strongly hyperproliferative in K5cre-
CMVcaNrf2 transgenic mice at P32 (Fig 3C). Consistent with the
milder acanthosis in older animals (Fig 3A), the rate of
proliferation declined in 6-month-old mice (Fig 3C). The
hyperproliferation observed in vivo is not a cell-autonomous
effect of Nrf2 activation as demonstrated by the normal
proliferation rate of cultured keratinocytes (Fig 3D). Apoptotic
cells were rare in the epidermis of control mice and were evenEMBO Mol Med 4, 364–379 www.embomolmed.org
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Figure 2. Pharmacological activation of Nrf2 in the skin phenocopies genetic activation.
A. H&E staining of longitudinal skin sections from mice topically treated with vehicle, 10mM sulforaphane (sulfor) or 50mM tBHQ showing hyperkeratosis and
acanthosis in sulforaphane and tBHQ treated mice. Scale bar, 50mm. E, epidermis; HF, hair follicle; SC, stratum corneum.
B. qRT-PCR analysis of Nqo1, Gclc, Gclm and Gsta3 relative to Gapdh using RNAs from back skin of the differently treated mice (control, N¼3; vehicle, N¼ 3;
sulforaphane, N¼ 3; tBHQ, N¼3). Expression levels in untreated mice were arbitrary set to 1 (dashed line).
C. Thickness of the viable epidermis in untreated (N¼10), vehicle (N¼ 6, p¼ 0.0022), sulforaphane (N¼ 6, p¼ 0.0022) or tBHQ (N¼6, p¼0.0012) treated
WT mice.
D. Thickness of the viable epidermis in WT and Nrf2 ko mice treated with vehicle or tBHQ. Epidermal thickness increased in WT mice (N¼ 15/17, p¼ 0.0003),
but not in Nrf2 ko mice (N¼ 17/5, p¼ 0.0118).further reduced in transgenicmice (Fig 3E). Thus, the acanthosis
in K5cre-CMVcaNrf2 transgenic mice results predominantly
from enhanced keratinocyte proliferation.
K5cre-CMVcaNrf2 mice have a disturbed epidermal barrier
We next determined if the acanthosis and hyperkeratosis result
from induction of compensatory mechanisms due to distur-
bance of the epidermal barrier as seen in patients with ichthyosiswww.embomolmed.org EMBO Mol Med 4, 364–379(Proksch et al, 2008). Therefore, we measured the transepi-
dermal water loss (TEWL) on the back skin to determine if the
inside-out barrier function is affected. No difference was seen
between control and transgenic mice at P2.5 (Fig 3F), but TEWL
was significantly increased in transgenic mice at P10 (2x), P32
(2.5x) and 6 months (6m) (2x; Fig 3F). This time course
correlates with the establishment of the phenotype in the
first postnatal weeks and the milder phenotype in aged mice. 2012 EMBO Molecular Medicine 367
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Figure 3. Hyperproliferation, impaired barrier function and inflammation in K5cre-CMVcaNrf2 mice.
A. H&E staining of P32 (upper panel) and 6 months (lower panel) K5cre-CMVcaNrf2 and control skin sections. Scale bar, 100mm.
B. Immunofluorescence analysis of Lor, Inv, K10, K14 and K6 (red), counterstained with Hoechst (blue). Scale bars, Lor, Inv, K10 and K14, 30mm; K6, 50mm. E,
epidermis; HF, hair follicle; SC, stratum corneum.
C. BrdU positive cells per length epidermis at P32 (p¼0.0004) and 6 months of age (p¼ 0.0004).
D. Percentage of BrdU positive subconfluent primary keratinocytes from tg/wt and tg/tg mice.
E. TUNEL positive cells per length epidermis at P32 (N¼ 4/5, p¼0.063).
F. TEWL at P2.5 (N¼4/2), P10 (N¼ 8/4, p¼0.0016), P32 (N¼ 10/6, p¼0.0002) and 6 months (N¼11/12, p<0.0001).
368The increased TEWL provides a likely explanation for the
skin dryness and may underlie at least in part the reduction in
body weight (see Fig 1D and Fig S1A of Supporting
information).
A defect in the epidermal barrier frequently initiates an
inflammatory response (Elias, 2010). Indeed, immunofluores-
cence and histochemical staining of P32 skin revealed an
increase in the number of dermal T cells (CD3þ), mast cells
(toluidine blue staining) and neutrophils (Ly-6Gþ) in K5cre-
CMVcaNrf2 mice, while numbers of macrophages (macrophage
specific lectin) and epidermal T cells (CD3þ) were normal 2012 EMBO Molecular Medicine(Fig 4A and Fig S1C and D of Supporting information). This
correlated with enhanced mRNA levels of the pro-inflammatory
cytokines interferon-g (Ifng), interleukin-1b (Il1b), Il6 and
tumour necrosis factor-a (Tnfa) at P32, while expression of
thymic stromal lymphopoietin (Tslp), a driver of allergic asthma
(Demehri et al, 2009), was even slightly downregulated (Fig 4B).
Since there was no inflammatory infiltrate and only an increase
in Il1b expression at P2.5 (Fig 4B), the inflammation is most
likely a consequence of the epidermal barrier defect, which
develops in the first days of postnatal development as shown by
TEWL (see Fig 3F).EMBO Mol Med 4, 364–379 www.embomolmed.org
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Figure 4. Inflammation in K5cre-CMVcaNrf2
mice.
A. Number of CD3 positive T cells, toluidine blue
positive mast cells and Ly-6G positive neutrophils
per area dermis at P2.5 and P32 (CD3: N¼5/4 for
P2.5 mice, N¼ 7/5, p¼0.0732 for P32 mice;
toluidine blue: N¼ 6/5 for P2.5 mice, N¼8/6,
p¼ 0.0013 for P32 mice; Ly-6G: N¼ 8/6,
p¼ 0.0047 for P32 mice).
B. qRT-PCR of Ifng , Il1b, Il6 and Tnfa and Tslp
relative to Gapdh using RNAs from P2.5 (left,
N¼2/3) and P32 (right, N¼ 3) tg/wt and tg/tg
mice. At P2.5 Ifng RNA was not detectable.
C. qRT-PCR of Csf2, Csf3 and Hgf relative to Gapdh
using RNAs from the skin of tg/wt and tg/tg
K5cre-CMVcaNrf2 mice at P2.5 (N¼ 2/3), P32
(N¼3) and 6 months (N¼ 3). Expression levels of
control mice were arbitrarily set to 1 (dashed
lines).The progressive inflammation also provides a likely explana-
tion for the acanthosis. IL6 is a keratinocyte mitogen (Werner
et al, 2007), and its overexpression may contribute to the
hyperproliferation in K5cre-CMVcaNrf2 mice. Furthermore, the
keratinocyte mitogens colony stimulating factor 2 (Csf2), Csf3
and hepatocyte growth factor (Hgf), which are upregulated by
pro-inflammatory cytokines (Szabowski et al, 2000), were
expressed at higher levels at P32, but not at P2.5 or 6 months of
age (Fig 4C). This time course of expression also reflects the
progression and amelioration of the phenotype (see Fig 3A).
Tight junctional permeability is not affected in caNrf2
transgenic mice
The physical barrier of the epidermis is formed by the protein-
enriched corneocytes (CO) with their cornified envelope (CE)
and by lipid-enriched intercellular domains. In addition,
corneodesmosomes as well as tight junctions in the granular
layer contribute to the barrier (Proksch et al, 2008). We
therefore analysed these components in our mice.
Ultrastructural analysis revealed enlarged intercellular spaces
in the granular layer of the epidermis of P32 K5cre-CMVcaNrf2
mice (Fig 5A). However, there was no major difference in the
number of desmosomes in the granular layer.www.embomolmed.org EMBO Mol Med 4, 364–379Since tight junctions are important components of the
epidermal barrier (Furuse et al, 2002; Yang et al, 2010), we
tested their functionality. For this purpose we performed a
diffusion assay by intradermal injection of a 600Da sulfo-NHS-
LC-biotin into the tail skin. In control mice, sulfo-NHS-LC-biotin
was detected in the intercellular space of keratinocytes up to the
upper part of the granular layer, where tight junctions are
located that prevent further diffusion (Furuse et al, 2002). A
similar distribution was observed in K5cre-CMVcaNrf2 mice,
indicating that tight junction permeability is not grossly affected
(Fig 5B).
Abnormal epidermal lipid metabolism in K5cre-CMVcaNrf2
mice
To determine if epidermal lipids are affected in K5cre-
CMVcaNrf2 mice, we analysed the lamellar bodies (LB), which
are lipid packed granules formed in differentiated keratinocytes.
Ultrastructural analysis revealed malformed LB in P32 K5cre-
CMVcaNrf2 mice with disoriented lamellae and/or a reduction
or total loss of lamellae (Fig 5C). The number of LB was
increased. This correlated with the severity of LB malformation,
indicating an attempt to compensate for their morphological and
consequently functional impairment. Free lamellar structures 2012 EMBO Molecular Medicine 369
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Figure 5. Abnormalities in lamellar bodies and epidermal lipids in K5cre-CMVcaNrf2 mice.
A. Electron microscopy of stratum granulosum (SG) keratinocytes of tg/wt and tg/tg mice at P2.5 and P32. Arrow points to the broadened intercellular space in
tg/tg mice. Scale bar: 0.3mm. DJ, desmosomal junction; TJ, tight junction; ICS, intercellular space.
B. Upper panel: Tight junction permeability assay using sulfo-NHS-LC-Biotin (red), counterstained with Hoechst (blue). Lower panel: Bright field image of the
same microscopic field. Arrows point to plasma membranes where diffusion of sulfo-NHS-LC-Biotin is stopped. Dashed line in the lower panel indicates
boundary between SG and SC. Scale bar, 10mm.
C. Electron microscopy of SG keratinocytes of tg/wt and tg/tg mice. Note the LB abnormalities, including disoriented lamellae, reduction of lamellae, complete
loss of lamellae or lamellae without surrounding membrane in keratinocytes of the SG in tg/tg mice (indicated by arrow). Scale bar, 0.2mm.
D. Electron microscopy of CO of tg/wt and tg/tg mice. Note the presence of lamellar bodies in the CO of tg/tg mice (indicated by arrow). Scale bar, 0.2mm.
E. Oil Red O staining of the SC. Note staining between SC layers. Scale bar, 10mm.
F. Amount (in mg) of cholesterol, free fatty acids and ceramides relative to the SC wet weight (in mg).
G. HPTLC analysis of SC lipids. Cer, ceramide; Chol, cholesterol; FFA, free fatty acid. Standard contains the SC ceramides Cer [AP], Cer [NP], Cer [NS] and Cer [EOS],
which differ with regard to hydroxylation of sphingoid base and fatty acid residues as well as esterification with another fatty acid (Farwanah et al, 2007).
H. qRT-PCR analysis of Elovl1, Elovl3, Elovl4, Elovl5, Elovl6, Elovl7 relative to Gapdh using RNAs from skin of P2.5 (left, N¼2/3) and P32 (right, N¼ 3) K5cre-
CMVcaNrf2 relative to control mice. Expression levels of control mice were arbitrary set to 1, indicated by dashed line.
370  2012 EMBO Molecular Medicine EMBO Mol Med 4, 364–379 www.embomolmed.org
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layer of K5cre-CMVcaNrf2 mice (Fig 5C), and occasionally we
observed LB in the cytoplasm of CO (Fig 5D). Thus, LB secretion
is also disturbed in K5cre-CMVcaNrf2 mice. Nevertheless, lipid
secretion and/or formation of the CE seem to occur as revealed
by neutral lipid OIL RED O staining (Fig 5E).
Quantification of SC lipids showed a 76% increase in
ceramides relative to the SC weight in caNrf2-transgenic mice,
while free fatty acids and cholesterol were similar in mice of
both genotypes (Fig 5F). High performance thin layer chroma-
tography (HPTLC) analysis of the SC revealed alterations in the
distribution of the different classes of ceramides, indicating a
change in ceramide modification, such as, for example
hydroxylation, desaturation and/or elongation (Fig 5G).
The length ofv-hydroxy long chain fatty acids is critical for an
efficient contribution of ceramides to the barrier (Cameron et al,
2007; Li et al, 2007; Westerberg et al, 2004). Long chain fatty
acid elongation is a multistep process, with the rate-limiting
initial step being catalysed by long-chain fatty acid elongation
factors (Elovls; Guillou et al, 2010). A significant upregulation of
Elovl3, 4, 6 and 7 was found in P32 K5cre-CMVcaNrf2 mice
(Fig 5H). Since Elovls are predominantly regulated at the
transcriptional level (Guillou et al, 2010), their upregulation
most likely results in an increase in long chain fatty acids. This
could at least in part explain the shift in the ceramide pattern
seen in the HPTLC analysis. At P2.5, we could not detect obvious
alterations in LB morphology and secretion, and upregulation of
Elovls was not yet observed at this age (Fig 5H). Therefore, the
alterations in lipid metabolism and LB formation and secretion
are obviously not a direct effect of Nrf2 activation, but rather a
consequence of other epidermal abnormalities.
Upregulation of Slpi, Sprr2d and Sprr2h in K5cre-CMVcaNrf2
mice
Ultrastructural analysis of the SC of P32 K5cre-CMVcaNrf2 mice
revealed CO with a translucent cytoplasm in the lower layers of
the SC and a thickening of the CO, especially in the back skin
(Fig 6A). A regionally restricted thickening of CO was already
observed at P2.5, suggesting that alterations in CO are an early
abnormality and potentially a direct consequence of Nrf2 action.
Processing of filaggrin (Flg), which is required for keratin
bundling and thus flattening of keratinocytes, however, was
normal in P32 K5cre-CMVcaNrf2 mice (Fig 6B). Furthermore, we
did not find alterations in the expression of Lor (Fig 6E).
Therefore, we wondered if other components of the CE are
differentially expressed at this early stage. To address this
question we performed a microarray analysis to compare the
gene expression pattern in the skin of P2.5 control and K5cre-
CMVcaNrf2 transgenicmice. Analysis of the array data revealed a
strong upregulation of various known Nrf2 target genes involved
in ROS detoxification and/or glutathione metabolism (Table SI of
Supporting information). These data further confirm the
usefulness of our transgenic model to study Nrf2 function.
Among 80 annotated genes, which were more than twofold
regulated in either direction, we only identified six genes, for
which a role in CE formation and/or epidermal barrier function
had been demonstrated (Table 1). These encode the secretorywww.embomolmed.org EMBO Mol Med 4, 364–379leukocyte peptidase inhibitor (Slpi), the small proline rich
proteins (Sprr) 2d and Sprr2h, keratin 16 (K16), cytochrome
P450 family 2 subfamily b polypeptide 19 (Cyp2b19) and
peroxisome proliferator activator receptor beta/delta (PPARb/d).
K16 is upregulated in sulforaphane treated skin (Kerns et al,
2007), and overexpression of K16 in a transgenic mouse model
resulted in hyperkeratosis and barrier disturbance (Presland et al,
2004). However, there was only a transient postnatal upregula-
tion of K16 in K5cre-CMVcaNrf2 transgenic mice as determined
by immunofluorescence staining (Fig S1E of Supporting
information). A role of PPARb/d in cutaneous homeostasis
and barrier formation has recently been shown (Man et al, 2008).
Cyp2b19 is an arachidonic acid epoxygenase, and the resulting
product activates transglutaminase, suggesting a role in CE
formation (Ladd et al, 2003). Using quantitative polymerase
chain reaction (after reverse transcription) (qRT-PCR) analysis
we found only a marginal upregulation of Cyp2b19 and PPARb/d
expression in P2.5 and P32 K5cre-CMVcaNrf2 transgenic mice
(Fig S1F and G of Supporting information). Therefore, a major
role of these genes in the development and progression of the skin
phenotype of K5cre-CMVcaNrf2 mice seems unlikely.
Slpi was previously identified as an Nrf2 target in alveolar
macrophages (Ishii et al, 2005). In the epidermis Slpi inhibits the
serine protease kallikrein 7 (Klk7; Franzke et al, 1996), which is
involved in SC desquamation by degradation of corneodesmo-
some proteins (Caubet et al, 2004). Thus, upregulation of Slpi is
likely to result in reduced desquamation. Enhanced expression
of Slpi in P2.5 K5cre-CMVcaNrf2 mice was confirmed by qRT-
PCR, and a more than 30-fold increase in expression compared
to control mice was seen at this early stage (Fig 6C). Slpi
expression was already increased at P0.5 (Fig S2A of Supporting
information), suggesting that its upregulation in K5cre-
CMVcaNrf2 mice is a primary effect of Nrf2 activation.
Consistent with the severe hyperkeratosis in adult mice (see
Fig 3A), a more than 100-fold increase in Slpi mRNA levels was
seen at P32 (Fig 6C).
To determine if the Slpi upregulation is indeed functionally
important, we analysed the corneodesmosomes. In K5cre-
CMVcaNrf2 mice corneodesmosomes were indeed still present
in the most upper layers of the hyperthickened SC as determined
by immunofluorescence staining for desmoplakin (Dpn; Fig S2B
of Supporting information). Ultrastructural analysis of the
corneodesmosomes in control and K5cre-CMVcaNrf2 mice
revealed a delay in corneodesmosome degradation in transgenic
mice (Fig 6D). This suggests that the upregulation of Slpi is
involved in the hyperkeratosis of caNrf2 transgenic mice by
inhibition of the Klk7-mediated degradation of CO and
subsequent desquamation.
Sprrs are important components of the CE (Patel et al, 2003),
which are cross-linked to Lor during CE formation. The
upregulation of Sprr2d and Sprr2h in P2.5 K5cre-CMVcaNrf2
mice was confirmed by qRT-PCR (Fig 6E). Consistent with the
array data, expression of Sprr1a was not regulated. At P0.5,
levels of Sprr2h and particularly of Sprr2dmRNAs were already
increased (Fig S2A of Supporting information) demonstrating
that their enhanced expression correlates with the early
morphological alterations of the CO. Expression of Sprr2d 2012 EMBO Molecular Medicine 371
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Figure 6. Corneocyte abnormalities and upregulation of Slpi, Sprr2d and Sprr2h in K5cre-CMVcaNrf2 mice.
A. Electronmicroscopy of the upper epidermis in P32 tg/wt and tg/tg mice. Bar in lower panel indicates thickness of the first corneocyte in the SC connected to the
stratum granulosum (SG) in tg/wt and tg/tg mice. Arrow in upper panel of tg/tg mice points to corneocyte with translucent cytoplasm. Scale bars, 1mm (left
panel); 0.2mm (right panel).
B. Western blot analysis of skin lysates for Flg and b-actin.
C. qRT-PCR of Slpi relative to Gapdh using skin RNAs from P2.5 (N¼2/3), P32 (N¼ 3) and 6 months (N¼3) tg/tg and tg/wt mice. Expression levels of control mice
were arbitrarily set to 1 (dashed line).
D. Electron microscopy of the lower (left panel) and upper (right panel) SC in P32 tg/wt and tg/tg mice. Corneodesmosomes are indicated by arrows and shown at
high magnification in the lower panel. CO are numbered from basal to suprabasal (C1–C5). Note partially degraded corneodesmosomes of lower and upper CO
in tg/wt mice, but intact corneodesmosomes in tg/tg mice. Scale bars, 0.1mm, upper and lower panel.
E. qRT-PCR of Lor, Sprr1a, Sprr2d and Sprr2h relative to Gapdh using skin RNAs from P2.5 (N¼2/3), P32 (N¼3) and 6 months (N¼3) tg/tg and tg/wt mice.
F. Immunohistochemical staining of tail skin sections with an Sprr2 antibody or without primary antibody (control). Scale bars, 30mm.
G. Ultrasound treatment of dissociated CO. Upper panel: Representative picture of untreated CO (top) and of CO after 10min of sonication (bottom). Arrows point
to intact CO, arrowheads to cell debris of damaged CO. Graph: Percentage of intact CO after 2–20min of sonication relative to untreated CO. Note faster
destruction of tg/tg compared to tg/wt CO.
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Matthias Scha¨fer et al.further increased in transgenicmice at P32, but declined again in
6-month-old mice (Fig 6E). This correlates with the strong
phenotype and increase in TEWL at P32 (Fig 3A, F). Sprr2h, in
contrast, was already downregulated at P32 (Fig 6E). A strong
increase in the expression of Sprr2s in P32 K5cre-CMVcaNrf2
was also observed by immunohistochemistry using an antibody
that detects multiple Sprr2 variants (Fig 6F).
We next investigated whether the upregulation of Sprrs in
caNrf2 transgenic mice impairs the mechanical stability of the
CO.We therefore isolated these cells from back skin of P2.5mice
and subjected them to ultrasound treatment (Koch et al, 2000).
Dissociated CO of K5cre-CMVcaNrf2 mice appeared morpholo-
gically normal, but ultrasound treatment resulted in a faster
destruction of CO from caNrf2-expressing mice compared to
control animals (Fig 6G). This was also observed for CO from the
tail of P32 K5cre-CMVcaNrf2 mice (Fig S2C of Supporting
information).Figure 7. Regulation of Slpi, Sprr2d and Sprr2h by Nrf2.
A,B. qRT-PCR of Slpi, Lor, Sprr2d and Sprr2h relative to Gapdh using RNAs from P
primary keratinocytes of tg/tg and tg/wt mice (B).
C. qRT-PCR of Slpi, Sprr2d and Sprr2h relative to Gapdh using RNAs from prim
indicated.
D. Model of Nrf2 action in the epidermis of K5cre-CMVcaNrf2 mice. Left: Nrf2 ac
upregulation reduces desquamation by inhibition of Klk7. Sprr2d and Sprr2h
mice inhibition of desquamation causes severe hyperkeratosis. The change in
SC. Furthermore, LB abnormalities, defects in their secretion and changes in
resulting in skin dryness and initiation of an inflammatory response with subs
Cytokines are involved in alterations of lipid metabolism. Keratinocyte mitoge
of keratinocytes, leading to acanthosis and acceleration of the hyperkerato
www.embomolmed.org EMBO Mol Med 4, 364–379Slpi, Sprr2d and Sprr2h are novel Nrf2 targets in
keratinocytes
Finally we investigated the mechanism of Slpi, Sprr2d and
Sprr2h regulation by Nrf2. Upon topical administration of tBHQ
or sulforaphane to WT mice we observed upregulation of Slpi
and Sprr2d, but not of Sprr2h and Lor (Fig 7A and Fig S2D of
Supporting information). Enhanced expression of Slpi and
Sprr2dwas also observed in primary keratinocytes isolated from
P4 K5cre-CMVcaNrf2 mice (Fig 7B).
When primary keratinocytes fromWTmice were treated with
tBHQ, we found a strong upregulation of Slpi, Sprr2d and Sprr2h
(Fig 7C). The increase in Sprr2d and Sprr2h expression was in a
similar range as the upregulation of the established Nrf2 target
Nqo1, and the upregulation of Slpi was only slightly lower
(Fig S2E of Supporting information). Most importantly, the
increase in Slpi, Sprr2d and Nqo1 expression was not observed
upon tBHQ treatment of keratinocytes fromNrf2 komice (Fig 7C10 tBHQ-creamed (N¼3) and vehicle-creamed (N¼3) wt mice (A) and from
ary keratinocytes of WT and Nrf2 ko mice treated with vehicle or tBHQ as
tivation initially leads to an increase in Slpi, Sprr2d and Sprr2h expression. Slpi
upregulation causes alterations in the composition of the CE. Right: In adult
the CE composition results in corneocyte fragility and consequent cracks in the
lipid metabolism occur. These alterations impair the permeability barrier,
equent production of pro-inflammatory cytokines and keratinocyte mitogens.
ns produced by inflammatory cells and/or fibroblasts cause hyperproliferation
sis.
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374and Fig S2E of Supporting information). Sprr2h upregulation
was reduced upon loss of Nrf2, although not completely
abolished (Fig 7C). These findings indicate that Slpi, Sprr2d and
Sprr2h are direct targets of Nrf2 and that their upregulation in
K5cre-CMVcaNrf2 mice is not the consequence of other
epidermal abnormalities.
In K14dnNrf2 transgenic mice, in which Nrf signalling is
blocked in keratinocytes by expression of a dominant-negative
mutant (auf dem Keller et al, 2006), there was no downregulation
of Slpi, Sprr2d and Sprr2h (Fig S2F of Supporting information).
Therefore, the basal Nrf2 activity is obviously not sufficient for
Slpi, Sprr2d and Sprr2h regulation. Rather, activated Nrf2 is
required for their regulation under stress conditions.DISCUSSION
Genetic and pharmacological activation of Nrf2 in the skin
causes ichthyosis-like abnormalities
Pharmacological activation of Nrf2 is a promising approach for
the prevention and/or therapy of major human diseases. In the
skin, Nrf2 activators protected the epidermis from UV-induced
cell damage (Dinkova-Kostova et al, 2006) and ameliorated the
blistering in a mouse model of epidermolysis bullosa simplex
(Kerns et al, 2007). However, it may also have undesired effects
as suggested by the phenotype of Keap1 ko mice (Wakabayashi
et al, 2003).
Here, we show that genetic or pharmacological Nrf2
activation causes severe skin abnormalities, which resemble
those of ichthyosis patients (Hohl &Williams, 2011). Therefore,
the dosage and duration of a topical treatment with Nrf2
activators needs to be determined for each compound and
indication. In addition, it would be important to identify
compounds that selectively induce the protective response but
not the epidermal abnormalities. This requires a thorough
understanding of the mechanisms underlying the Nrf2-induced
acanthosis and hyperkeratosis. In this study we addressed these
mechanisms and we identified novel and unexpected activities
of Nrf2 in CE and epidermal barrier formation. These results
reveal that multiple epidermal defense mechanisms are tightly
linked through Nrf2.
Nrf2 activation causes keratinocyte hyperproliferation and
acanthosis
The availability of a viable mouse model with an Nrf2 gain-of-
function allowed us to address the mechanisms underlying theTable 1. Genes involved in epidermal barrier formation with 2-fold change (p
control mice.
Symbol Gene name
Slpi Secretory leukocyte peptidase inhibitor
Sprr2d Small proline-rich protein 2D
Sprr2h Small proline-rich protein 2H
Krt16 Keratin 16
Cyp2b19 Cytochrome P450 family 2 subfamily b polypeptide
Pparb/d Peroxisome proliferator activator receptor beta/delt
 2012 EMBO Molecular Medicineepidermal phenotype. We found that the severe acanthosis
resulted predominantly from an increase in keratinocyte
proliferation. Although activated Nrf2 enhanced the prolifera-
tion of certain tumour cells in vitro (Homma et al, 2009; Reddy
et al, 2008), this was not the case for cultured keratinocytes from
caNrf2 transgenic mice. Rather, the hyperproliferation seen
in vivo is most likely a consequence of a disturbed epidermal
barrier as seen in other mouse lines with barrier defects
(Djalilian et al, 2006; Yang et al, 2010), in WT mice after acute
barrier disruption (Wood et al, 1992), and in patients suffering
from diseases with an impaired epidermal barrier, such as
psoriasis, atopic dermatitis and ichthyoses (Elias et al, 2008;
Proksch et al, 2008; Wagner et al, 2010). These conditions are
also characterized by cutaneous inflammation.
K5cre-CMVcaNrf2 mice showed an increase in the number of
mast cells, T-cells and neutrophils and enhanced expression of
several pro-inflammatory cytokines at P32. At P2.5, no change
in immune cell number and only a slight upregulation of Il1b
was observed. This correlates with the onset of the barrier
defect, which was first detected at P10. Thus, the inflammation
is most likely the consequence of the barrier defect. Activated
immune cells frequently produce keratinocyte mitogens or
induce their production by adjacent fibroblasts (Werner et al,
2007). This was also observed in K5cre-CMVcaNrf2 mice,
indicating that caNrf2 affects keratinocyte proliferation through
induction of a paracrine loop involving inflammatory cells and
possibly mesenchymal cells of the dermis (Fig 7D). This
provides a likely explanation for the acanthosis and may also
contribute to the hyperkeratosis.
The phenotype of K5cre-CMVcaNrf2 mice is most similar to
the abnormalities seen in patients with lamellar ichthyosis. This
is based on three histological criteria: An acanthotic epidermis
with 4–7 malpighian layers, a massive hyperorthokeratosis
lacking histological atypia, and a mild erythema with only a
slight increase in mononuclear infiltrate and moderate increase
inmast cells and neutrophils (Fig S3 of Supporting information).
However, a direct comparison of the mouse phenotype with the
human disease is limited by the anatomical differences between
murine and human skin.
Activation of Nrf2 interferes with corneocyte desquamation
The major reason for the severe hyperkeratosis in caNrf2
transgenic mice is most likely the upregulation of Slpi. It was
previously shown that Slpi inhibits Klk7 (Franzke et al, 1996),
which is involved in the desquamation of the SC by degradation
of corneodesmosomes (Borgono et al, 2007; Caubet et al, 2004).< 0.005) in microarray using back skin RNA of P2.5 K5cre-CMVcaNrf2 and
Fold Change Reference
6.3 Caubet et al (2004)
5.2 Patel et al (2003)
3.2 Patel et al (2003)
3.1 Presland et al (2004)
19 2.0 Ladd et al (2003)
a 2.0 Man et al (2008)
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some degradation is indeed delayed in K5cre-CMVcaNrf2 mice.
Thus, the strong upregulation of Slpi in K5cre-CMVcaNrf2 mice
is likely to impair corneodesmosome degradation by inhibition
of Klk7, resulting in delayed desquamation. This is the likely
mechanism underlying the severe hyperkeratosis in these mice.
Regulation of Slpi by Nrf2 had previously been shown in
alveolar macrophages, and Slpi was identified as a direct target
of Nrf2 using reporter assays. Nrf-mediated upregulation of Slpi
and the resulting inhibition of elastase activity contributed to the
anti-inflammatory and protective function of Nrf2 in pulmonary
diseases (Ishii et al, 2005). Furthermore, an antimicrobial
function of Slpi against fungi and bacteria and an antioxidant
function had been demonstrated (Doumas et al, 2005;Wiesner &
Vilcinskas, 2010). The identification of Slpi as a target of Nrf2 in
keratinocytes (this study) therefore suggests that it may
contribute to an anti-inflammatory, antimicrobial and antiox-
idant function of Nrf2 in the epidermis.
Activation of Nrf2 results in cornified envelope instability and
consequent barrier disturbance
While the upregulation of Slpi provides a likely explanation for
the hyperkeratosis in K5cre-CMVcaNrf2 mice, it does not
explain the barrier function defect. Barrier abnormalities may
result from alterations in lipid metabolism and LB formation/
secretion (Elias et al, 2008) or from defective tight junctions
(Hadj-Rabia et al, 2004). The latter possibility was excluded,
since the tight junctional permeability was obviously not
affected. By contrast, we found a severely alteredmorphology of
LB and disturbed LB secretion. Abnormalities in LB were seen in
mouse models of ichthyoses resulting from mutations in genes
involved in lipid metabolism (Elias et al, 2008). Indeed, the
levels of ceramides were elevated and the ceramide composition
was altered in the SC of K5cre-CMVcaNrf2 mice. This is likely to
result from enhanced expression of different Elovls and a
consequent increase in long chain fatty acids. Interestingly, mice
lacking Elovl3 or Elovl4 show a compromised epidermal barrier
due to altered lipid composition (Vasireddy et al, 2007;
Westerberg et al, 2004). In the future it will be interesting to
study whether overexpression of these genes impairs or
improves the epidermal barrier. The increase in ceramides
could also be the consequence of elevated cytokine expression,
since TNF signalling activated sphingomyelinase in keratino-
cytes (Jensen et al, 1999). Independent of the underlying
mechanism, the lipid abnormalities were obviously not a direct
consequence of Nrf2 activation, since they occurred rather late
during postembryonic development. Rather, our ultrastructural
data revealed early abnormalities in the CE. Expression of Flg,
which is mutated in a large percentage of patients with
ichthyosis vulgaris or atopic dermatitis (Sandilands et al,
2009), was enhanced in adult K5cre-CMVcaNrf2 mice, but the
protein was normally processed. Furthermore, upregulation of
Flg mRNA was not yet observed at P2.5 (microarray data).
However, an early and strong upregulation of Sprr2d and Sprr2h
occurred, while expression of Lor was unaltered. Sprr2 proteins
are cross-linked to Lor by transglutaminase and form an integral
part of the CE. In Lor ko mice a change in the mechanicalwww.embomolmed.org EMBO Mol Med 4, 364–379stability of the CO had been shown (Koch et al, 2000), which
was similar to the defect observed in K5cre-CMVcaNrf2 mice.
Thus, the increase in Sprr2d and Sprr2h expression and the
consequent abnormal composition of the CE may well be
responsible for the CO fragility. Consistent with this assump-
tion, epidermal barrier disturbances were observed in several
mouse models with defects in CE proteins (Scharschmidt et al,
2009; Sevilla et al, 2007), and mutated Sprr3 was recently
identified as a risk factor for atopic dermatitis (Marenholz et al,
2011). Thus, the early upregulation of Sprr2 genes and
consequent CE abnormalities are likely to represent the primary
defect in K5cre-CMVcaNrf2 mice.
Alteredmorphology and disturbed secretion of LBwere seen in
mice with a frameshift mutation in the Flg gene that mimics some
mutations found in atopic dermatitis patients (Scharschmidt et al,
2009). This finding suggests that defects in the CE also affect LB
secretion and thus the composition of the extracellularmatrix that
normally forms the permeability barrier. This model implies that
the defects in lipid metabolism are secondary to the CE
abnormalities, a hypothesis that is supported by the time course
of events that we observed in our transgenic mice. The resulting
barrier defect causes skin dryness and initiates an inflammatory
response, which is likely to further impair epidermal lipid
metabolism (Jensen et al, 1999; Watson et al, 2007).
Sprrs are novel Nrf2 target genes that contribute to its
ROS-protective effect
The present study provides first evidence for a direct regulation of
Sprr2d and Sprr2h genes byNrf2. This conclusion is based on their
early upregulation in newborn skin of K5cre-CMVcaNrf2mice and
on the tBHQ-mediated upregulation in keratinocytes fromWT but
not from Nrf2 ko mice. Furthermore, classical Nrf2 binding sites
(antioxidant response element; ARE; Rushmore et al, 1991) are
present in the promoter regions of Sprr2d and Sprr2h (data not
shown). The identification of Sprr2s as novel Nrf2 targets provides
further insight into the mechanisms underlying the potent ROS-
protective effect of Nrf2 in the epidermis, since Sprrs are major
ROS-scavengers (Vermeij et al, 2011). Unfortunately, however,
chronic deregulated expression postnatally, in particular of
Sprr2d, also resulted in an adverse event, the development of
an ichthyosis-like skin disease. This undesired activity limits the
use of Nrf2 activators for skin protection under stress conditions.MATERIALS AND METHODS
Generation of caNrf2 transgenic mice
A vector allowing Cre-mediated expression of caNrf2 (Scha¨fer et al,
2010) was modified by cloning of a CMV enhancer in front of the b-
actin promoter (Sawicki et al, 1998). Transgenic mice were generated
by pro-nucleus injection (FVB/N background). Genotyping of founder
mice was performed by PCR (Scha¨fer et al, 2010) using CMVcaNrf2
primers (Table II of Supporting information).
Microarray analysis
Skin from female P2.5 K5cre-CMVcaNrf2 and control mice was
removed and snap frozen in liquid nitrogen. RNA purification, reverse 2012 EMBO Molecular Medicine 375
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The paper explained
PROBLEM:
The skin, which serves as a protective barrier against the
environment, is frequently challenged by harmful insults that
cause formation of reactive oxygen species (ROS). A central player
in the ROS defense is the transcription factor Nrf2, a promising
pharmacological target for skin protection and cancer preven-
tion. The consequences of long-term activation of Nrf2 in the
skin, however, are poorly understood. In addition, it was
previously unclear if Nrf2 also controls other components of the
epidermal barrier.
RESULTS:
We show that genetic or pharmacological activation of Nrf2 in
murine keratinocytes induced epidermal thickening and hyper-
keratosis resembling the human skin disease lamellar ichthyosis.
The discovery of three novel Nrf2 targets in keratinocytes
provides a mechanistic explanation for the phenotype: While
upregulation of the secretory leukocyte peptidase inhibitor (Slpi)
caused hyperkeratosis through inhibition of desquamation, Nrf2-
mediated expression of small proline-rich proteins (Sprr2) d
and h resulted in corneocyte fragility with a concomitant defect
in epidermal barrier function and development of inflammatory
skin disease. Activation of the Nrf2-Sprr2 and Nrf2-Slpi pathways
enhances the epidermal antioxidant and antimicrobial defense,
but prolonged and enhanced activation causes corneocyte
fragility and alterations in the epidermal barrier.
IMPACT:
The results described in this study identify Nrf2 as a central
regulator of various protective functions of the epidermis. While
these activities are generally beneficial, prolonged and enhanced
activation of these pathways is detrimental and limits the
therapeutic potential of Nrf2 activators.
376transcription, labelling, microarray hybridization and analysis were
performed as described earlier (Beyer et al, 2008). Microarray analysis
was performed using RNAs from three individual mice per genotype.
The microarray data have been deposited in NCBI’s Gene Expression
Omnibus (Edgar et al, 2002) and are accessible through GEO Series
accession number GSE35160 (http://www.ncbi.nlm.nih.gov/geo/query/
acc.cgi?acc=GSE35160).
Topical treatment of mice with Nrf2 activators
Mice were treated twice a day for 10 consecutive days starting at P0
with a 1:2 mixture of non-ionic hydrophilic cream (Ha¨nseler, Herisau,
Switzerland) and DMSO (vehicle) supplemented with 10mM sulfor-
aphane or 50mM tBHQ (both from Merck, Darmstadt, Germany) and
sacrificed by CO2 inhalation. All animal experiments had been
approved by the local veterinary authorities of Zurich, Switzerland
(Kantonales Veterina¨ramt Zu¨rich).
Morphometric analyses
Epidermal thickness was analysed by measurement of the inter-
follicular epidermal area and corresponding length on H&E stained
longitudinal paraffin sections (7mm) from mouse back skin. Morpho-
metrical analyses were performed using the Openlab 3.1.5 software
(Perkin Elmer, Waltham, MA).
Analysis of TEWL
TEWL was analysed on shaved posterior back skin of anesthetized
mice using a Tewameter (Courage and Khazaka Electronic GmbH,
Cologne, Germany). 50 consecutive and three independent measure-
ments were performed according to the manufacturer’s instructions.
Tight junction permeability assay
20–30ml of EZ-LinkTM Sulfo-NHS-LC-Biotin solution (Pierce Chemical
Co.; 10mg/ml in 1mM CaCl2/PBS) were intradermally injected into the 2012 EMBO Molecular Medicinetail skin of anesthetized adult mice. Mice were sacrificed 1 h after
injection and sulfo-NHS-LC-Biotin was detected on 7mm cryosections
(Furuse et al, 2002).
Isolation of corneocytes and ultrasound treatment
CO were isolated (Koch et al, 2000) and counted in a Neubauer chamber.
Equal amounts of CO from K5cre-CMVcaNrf2 and control mice were
suspended in the same volume and sonicated for 20min in a Branson
2510 cup sonicator (Branson Ultrasonics, Danbury, CT) at 48C. Every
2min an aliquot was taken and the number of intact CO was counted.
Lipid extraction and HPTLC
The SC was manually separated after 3h incubation of tail skin in 0.5%
trypsin in PBS at 378C and 30min sonication. Lipids were extracted
from SC using chloroform/methanol and water (2:1:0.8 by volume).
After a phase separation step the lower chloroform phase was used for
further analysis. Separation of the lipids on silica HPTLC plates was
performed using a solvent mixture consisting of n-hexane, diethyl ether
and acetic acid (70:30:1 by volume). A second chromatography step (to
the top of the plate) using chloroform, methanol and acetic acid
(190:9:1 by volume) allowed the separation of ceramides. Extractions of
samples from tg/wt and tg/tg mice were performed simultaneously.
The separated lipid bands were visualized by dipping the plates into an
aqueous solution containing 10% CuSO4, 8% H3PO4 (w/v) and
subsequent heating to 1608C for 10min. Thereafter, the visualized
lipid bands were scanned densitometrically in the reflectance mode at a
wavelength of 595nm using a TLC Scanner 3 (CAMAG, Berlin, Germany).
Quantitative results were obtained by relating the intensities of the
separated lipid bands to calibration curves of corresponding standards.
Replicate experiments and statistical analyses
For qRT-PCR and Western blot analyses, either single animals or pools
of skin samples from 2 to 3 mice from one litter or pools of 2 to 3EMBO Mol Med 4, 364–379 www.embomolmed.org
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Matthias Scha¨fer et al.dishes of cells were used, and all experiments were repeated with
independent samples. BrdU analyses were performed in triplicates.
Statistical analyses were performed using the non-parametric Mann–
Whitney U-test for non-Gaussian distribution and Prism 5.0 software
(GraphPad Software, La Jolla, CA). Error bars represent standard
deviation.
For more detailed Materials and Methods see the Supporting
information. Primers are listed in Table SII, antibodies in Table SIII of
Supporting information.Author contributions
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